NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis

NCT06128213 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infections
Pyelonephritis

Interventions

DRUG: NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl (lurasidone))

Sponsor

NeuroRx, Inc.